SuperworthBoston Scientific EPS BSX
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jun 30, 2026
- $2.47
- Latest quarter, Q2 FY26
- $0.61
- +15% on a year earlier
- Fiscal year 2025
- $1.94
- +55% on the year before
Boston Scientific's earnings per share was $2.47 over the twelve months to Jun 30, 2026, up 47% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.61, up 15% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $1.94 | +55% |
| FY2024 | $1.25 | +17% |
| FY2023 | $1.07 | +138% |
| FY2022 | $0.45 | −35% |
| FY2021 | $0.69 | n/a |
| FY2020 | −$0.08 | −102% |
| FY2019 | $3.33 | +180% |
| FY2018 | $1.19 | +1600% |
| FY2017 | $0.07 | −73% |
| FY2016 | $0.26 | n/a |
| FY2015 | −$0.18 | n/a |
| FY2014 | −$0.10 | n/a |
| FY2013 | −$0.08 | n/a |
| FY2012 | −$2.87 | −1090% |
| FY2011 | $0.29 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.61 | +15% | $2.47 | |
| Q1 FY26 | $0.90 | +100% | $2.39 | |
| Q4 FY25 | $0.45 | +18% | $1.94 | |
| Q3 FY25 | $0.51 | +59% | $1.87 | |
| Q2 FY25 | $0.53 | +141% | $1.68 | |
| Q1 FY25 | $0.45 | +36% | $1.37 | |
| Q4 FY24 | $0.38 | +12% | $1.25 | |
| Q3 FY24 | $0.32 | −6% | $1.21 | |
| Q2 FY24 | $0.22 | +22% | $1.23 | |
| Q1 FY24 | $0.33 | +57% | $1.19 | |
| Q4 FY23 | $0.34 | +278% | $1.07 | |
| Q3 FY23 | $0.34 | +183% | $0.82 |
Against its peers
Companies in Medical - Devices nearest Boston Scientific's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| BSXBoston Scientific | $2.47 | +47% a year |
| EWEdwards Lifesciences | $1.74 | −75% a year |
| SYKStryker | $9.65 | +28% a year |
| MDTMedtronic | $4.07 | +12% a year |
| GEHCGE HealthCare Technologies | $4.36 | −11% a year |
| DXCMDexCom | $2.52 | +76% a year |
| ABTAbbott Laboratories | $2.68 | −66% a year |
| ZBHZimmer Biomet | $4.11 | +0% a year |
| Peer median | $4.07 |
Where Boston Scientific ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Boston Scientific
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.